Leading Growth Driver in the Urethral Stricture Treatment Devices Market in 2025: Rising BPH Cases Propel Market Growth Driver's Influence

What Are the Market Size and Growth Forecast for the Urethral Stricture Treatment Devices Market?
In recent times, the market for urethral stricture treatment devices has experienced significant growth. The market is forecasted to expand from $1.37 billion in 2024 to $1.48 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.3%. The historical growth can be linked to factors such as an increase in occurrences of urethral strictures, more use of minimally invasive treatments, heightened awareness of urological conditions, increased health expendature in developed areas, and enhanced diagnostic capability.

There is expected to be substantial growth in the market size of urethral stricture treatment devices in the coming years, with projections estimating up to $2.01 billion in 2029 with a compound annual growth rate (CAGR) of 8.0%. What is driving this growth in that forecast period is the amplified demand for outpatient procedures, a greater emphasis on nurturing patient-centric care, an expansion of healthcare infrastructure in budding markets, increased incidents of trauma-related strictures, and health awareness initiatives led by healthcare bodies. Key trends during this forecast period encompass a shift towards less invasive surgical methods, the incorporation of artificial intelligence in diagnostic instruments, technology improvements in surgical apparatus, advancements in medical imaging procedures, and an emphasis on customised treatment plans.

What Is Contributing to the Growth of the Urethral Stricture Treatment Devices Market?
An influx in benign prostatic hyperplasia (BPH) and neurogenic bladder cases is expected to be a deciding force in the advancement of the urethral stricture treatment devices market. BPH, a condition frequently found among elderly men, is defined by an enlarged prostate gland that can cause urinary obstruction and elevate the risk of urethral strictures. The surge in BPH is mainly attributed to aging, particularly affecting men above 50, with other factors such as lifestyle, hormonal imbalances, and persistent health conditions accelerating its development. Urethral stricture treatment tools are regularly employed in urological disorders such as BPH, where complications after surgery or extended catheterization can result in the narrowing of the urethra. Interventions such as dilators, stents, or urethrotomy instruments are then required to re-establish regular urinary flow. As an illustration, a report from the Royal Pharmaceutical Society in September 2023 stated that nearly 3 million individuals in the UK suffer from BPH. The report observed its incidence to be roughly 50% in men aged 60-70 years soaring to 90% in those over 80 years. Hence, the escalating occurrences of BPH and neurogenic bladder is predicted to fuel the urethral stricture treatment devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20986&type=smp

Which Key Market Leaders Are Driving Urethral Stricture Treatment Devices Industry Growth?
Major companies operating in the urethral stricture treatment devices market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, Medline Industries LP., Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun SE, Olympus Corporation, Coloplast Ltd, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Medical, ConvaTec Inc., Ambu A/S, Richard Wolf GmbH, Laborie Medical Technologies, Bactiguard AB, UROMED Kurt Drews KG, Pnn Medical A/S, Hydrumedical SA, Allium Ltd., Med pro Medical B.V., Urotronic Inc., Rocamed SAM, Zhejiang ChuangXiang Medical Technology Co. Ltd

What Are the Major Trends Shaping the Urethral Stricture Treatment Devices Market?
Leading organisations in the urethral stricture treatment devices market are turning to strategic partnerships to bolster technology integration and market proliferation. A strategic partnership involves the synergy of different organisations who merge their abilities, resources and efforts to achieve mutual aims. Take for example; in April 2024, Laborie Medical Technologies Corp., an American company specialised in diagnostic and therapeutic medical technology, entered a partnership with NHS Specialized Services Device Programme (SSDP) incorporating its Optilume Urethral Drug-Coated Balloon (DCB) into the programme. This partnership ensures a payback model for NHS hospitals in England, encouraging broader patient access to this groundbreaking device. Optilume combines balloon dilation with an anti-proliferative drug delivery system to minimise the recurrence of urethral strictures. This less invasive technology offers a revolutionary alternative to traditional surgery or repeated treatments, addressing a significant gap in the urology sector.

What Are the Main Segments in the Urethral Stricture Treatment Devices Market?
The urethral stricture treatment devices market covered in this report is segmented -

1) By Product Type: Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, Urinary Catheters
2) By Stricture Location: Anterior, Posterior
3) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Urethral Dilators: Semi-Rigid Urethral Dilators, Flexible Urethral Dilators, Balloon Urethral Dilators, Graded Urethral Dilators
2) By Urethral Stents: Self-Expanding Urethral Stents, Balloon-Expandable Urethral Stents, Metallic Urethral Stents, Silicone Urethral Stents
3) By Urethral Balloon Dilation Catheters: Single-Balloon Dilation Catheters, Double-Balloon Dilation Catheters, Coaxial Balloon Dilation Catheters, Hydrophilic-Coated Balloon Dilation Catheters
4) By Urinary Catheters: Foley Urinary Catheters, Intermittent Urinary Catheters, External Urinary Catheters, Supra-Pubic Urinary Catheters

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/urethral-stricture-treatment-devices-global-market-report

Which Geographic Area Leads the Urethral Stricture Treatment Devices Market?
North America was the largest region in the urethral stricture treatment devices market in 2024. The regions covered in the urethral stricture treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Urethral Stricture Treatment Devices Global Market Report?

- Market Size Analysis: Analyze the urethral stricture treatment devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the urethral stricture treatment devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall urethral stricture treatment devices market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the urethral stricture treatment devices market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20986

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.